(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
(Sharecast News) - Avacta said on Thursday it had agreed the design of a pivotal US trial for its lead cancer therapy with the US Food and Drug Administration, while reporting further clinical data th...
(Alliance News) - Avacta Group PLC on Monday said it continued its "strong progress" in the first half of 2026.
(Sharecast News) - Avacta Therapeutics said on Monday that it had made strong progress across its oncology pipeline in the first half of 2026, including the start of clinical work for its second-gener...
Avacta Group PLC - London-based clinical-stage biopharmaceutical company - Raises gross proceeds of approximately GBP9 million from institutional investors and existing shareholders, through condition...
(Sharecast News) - Avacta announced on Friday that it had raised about £9m through an oversubscribed placing with institutional investors and existing shareholders, with the proceeds to be used t...